首页 > 市场调查报告书 > 医疗设备

e保健行动医疗

市场调查报告书

商品编码

1633677

智慧糖尿病管理市场规模、份额和成长分析（按设备类型、应用、最终用户和地区）- 2025-2032 年产业预测

Smart Diabetes Management Market Size, Share, Growth Analysis, By Device Type (Handheld, Wearable), By Application (Type 1 Diabetes, Type 2 Diabetes), By End User, By Region - Industry Forecast 2025-2032

出版日期: 2025年01月11日 | 出版商:

SkyQuest | 英文 205 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2023 年全球智慧糖尿病管理市场规模价值为 60.4 亿美元，预计将从 2024 年的 69.3 亿美元成长到 2032 年的 207.5 亿美元，预测期内（2025-2032 年）的复合年增长率为 14.7%。

由于医疗技术的进步和对个人化护理的重视，智慧糖尿病管理市场正在经历显着增长。这一市场扩张的推动因素是人们对糖尿病管理认识的不断提高、全球糖尿病患者数量的不断增加以及对创新监测和治疗工具的需求。製造商和医疗保健提供者专注于开发智慧型装置、穿戴式装置和行动应用程序，以改善糖尿病患者的生活品质、促进更好的疾病管理并最大限度地减少併发症。此外，人工智慧和资料分析的引入为更个人化、更有效的糖尿病照护提供了机会。随着健康和保健变得越来越重要，智慧糖尿病管理市场将透过为快速成长的糖尿病患者群体提供创新解决方案来保持其成长轨迹。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲国家
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲国家
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前 5 家公司对比
主要企业市场定位（2024年）
主要市场参与者所采用的策略
近期市场趋势
公司市场占有率分析（2024 年）
主要企业简介
- 公司简介
- 产品系列分析
- 按细分市场分析市场份额
- 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

Abbott Laboratories（United States）
Dexcom, Inc.（United States）
Medtronic plc（Ireland）
Insulet Corporation（United States）
F. Hoffmann-La Roche Ltd.（Switzerland）
Bayer AG（Germany）
Ascensia Diabetes Care Holdings AG（Switzerland）
Tandem Diabetes Care, Inc.（United States）
LifeScan, Inc.（United States）
AgaMatrix, Inc.（United States）
Glooko, Inc.（United States）
DarioHealth Corp.（Israel）
One Drop（United States）
Ypsomed Holding AG（Switzerland）
ARKRAY, Inc.（Japan）
ACON Laboratories, Inc.（United States）
Becton, Dickinson and Company（United States）
Care Innovations, LLC（United States）
Health2Sync, Inc.（Taiwan）
Emperra GmbH E-Health Technologies（Germany）

结论和建议

简介目录

Product Code: SQMIG35A2780

Global Smart Diabetes Management Market size was valued at USD 6.04 billion in 2023 and is poised to grow from USD 6.93 billion in 2024 to USD 20.75 billion by 2032, growing at a CAGR of 14.7% during the forecast period (2025-2032).

The smart diabetes management market is experiencing significant growth, driven by advancements in healthcare technology and an emphasis on personalized care. This expansion is fueled by heightened awareness of diabetes management, a rising global diabetic population, and the demand for innovative monitoring and treatment tools. Manufacturers and healthcare providers are focused on developing smart devices, wearables, and mobile applications to improve the quality of life for diabetes patients, facilitating better disease management and minimizing complications. Additionally, the incorporation of artificial intelligence and data analytics presents opportunities for more tailored and effective diabetes care. As health and wellness become increasingly prioritized, the smart diabetes management market is poised to sustain its growth trajectory, offering innovative solutions for a rapidly expanding population of diabetes sufferers.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Smart Diabetes Management market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Smart Diabetes Management Market Segmental Analysis

Global Smart Diabetes Management Market is segmented by Device Type, Application, End User and region. Based on Device Type, the market is segmented into Handheld and Wearable. Based on Application, the market is segmented into Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes and Other. Based on End User, the market is segmented into Hospitals, Home Care Settings, Specialty Clinics and Other. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Smart Diabetes Management Market

The Global Smart Diabetes Management market is significantly driven by remarkable technological advancements. Innovations in wearable devices, mobile applications, and data analytics tools are enabling individuals living with diabetes to monitor and manage their condition with increased efficiency. These state-of-the-art technologies not only improve the overall user experience but also equip healthcare providers with vital information, facilitating more personalized care and tailored treatment adjustments. As these tools continue to evolve, they promise to enhance the quality of life for diabetes patients while streamlining communication between patients and healthcare professionals, thereby propelling the market's growth and development.

Restraints in the Global Smart Diabetes Management Market

One of the major constraints facing the Global Smart Diabetes Management market is the high cost of implementation and accessibility. The significant initial investments required for advanced diabetes management devices and services create obstacles for individuals with lower incomes or those residing in areas with inadequate healthcare facilities. This lack of accessibility presents a challenge in ensuring that these innovative technologies reach all demographic segments, thereby impeding widespread acceptance and usage. Consequently, the financial burden associated with these smart solutions limits their availability and effectiveness in promoting better diabetes care across diverse populations.

Market Trends of the Global Smart Diabetes Management Market

The Global Smart Diabetes Management market is experiencing significant growth, primarily fueled by the rising prevalence of diabetes worldwide. As the global population ages and sedentary lifestyles proliferate, the incidence of diabetes is climbing, with millions seeking effective management strategies. This expanding patient demographic catalyzes demand for advanced solutions that offer enhanced monitoring and personalized care. Consequently, innovation in smart diabetes management technologies, including connected devices, mobile applications, and telehealth services, is accelerating, transforming traditional approaches. The convergence of healthcare technology and patient-centric solutions is pivotal for addressing the challenges of diabetes management, thus solidifying the market's positive trajectory toward the future.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Case Studies
Technology Advancement
Regulatory Landscape
Startup Analysis
Patent Analysis

Global Smart Diabetes Management Market Size by Device Type & CAGR (2025-2032)

Market Overview
Continuous Glucose Monitoring Systems
Smart Insulin Pens
Smart Insulin Pumps
Smart Glucose Meters
Other

Global Smart Diabetes Management Market Size by Device Type & CAGR (2025-2032)

Market Overview
Handheld
Wearable

Global Smart Diabetes Management Market Size by Application & CAGR (2025-2032)

Market Overview
Type 1 Diabetes
Type 2 Diabetes
Gestational Diabetes
Other

Global Smart Diabetes Management Market Size by End User & CAGR (2025-2032)

Market Overview
Hospitals
Home Care Settings
Specialty Clinics
Other

Global Smart Diabetes Management Market Size & CAGR (2025-2032)

North America (Device Type, Device Type, Application, End User)
- US
- Canada
Europe (Device Type, Device Type, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Device Type, Device Type, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Device Type, Device Type, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Device Type, Device Type, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Abbott Laboratories (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dexcom, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Insulet Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche Ltd. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bayer AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ascensia Diabetes Care Holdings AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Tandem Diabetes Care, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LifeScan, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AgaMatrix, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Glooko, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DarioHealth Corp. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
One Drop (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ypsomed Holding AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ARKRAY, Inc. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ACON Laboratories, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Care Innovations, LLC (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Health2Sync, Inc. (Taiwan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Emperra GmbH E-Health Technologies (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments